IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellicum Pharm., Inc. 5

Q2 2019 vs Q3 2019

Comparing institutional holders between quarters

Quarters

Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Knott David M
UNCHANGED
Shares100 from 100
Change0 (0%)
Value$1 (-$49)
Filed 2019-11-12
Status
Knott David M
UNCHANGED10010000%$50$1-$492019-11-12
Showing 1 of 1 institutions